The updated certification enables Hedia to support younger patients through both its standalone application and integrated partner digital health platforms. By accommodating flexible insulin regimens tailored to pediatric needs, the company aims to improve glycemic control for children and teens managing type 1 diabetes. The software now provides seamless data synchronization across continuous glucose monitors, smart pens, and wearable devices, bridging the gap between home-based care and professional clinical oversight.
CEO Rasmus Kofoed emphasized that the move targets the specific precision required for pediatric care, linking clinics directly with families. Founded in 2016, the Copenhagen-based company plans to begin the rollout of these features shortly, focusing on streamlining daily therapy calculations and carbohydrate tracking for families and healthcare teams.


.jpg)

Comments (0)
No comments yet. Be the first!